ArticleOncology letters2012

EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel.

Pingqing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.